Profile data is unavailable for this security.
About the company
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.
- Revenue in SEK (TTM)137.00k
- Net income in SEK-97.60m
- Incorporated2000
- Employees6.00
- LocationAbliva ABMedicon Village, Scheeletorget 1LUND 223 81SwedenSWE
- Phone+46 462756220
- Fax+46 468888348
- Websitehttps://abliva.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scandion Oncology A/S | 0.00 | -56.46m | 180.00m | 4.00 | -- | 1.62 | -- | -- | -0.4246 | -0.4246 | 0.00 | 0.2643 | 0.00 | -- | -- | 0.00 | -74.59 | -- | -87.90 | -- | -- | -- | -- | -- | -- | -- | 0.0113 | -- | -- | -- | 48.89 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -37.43m | 183.93m | 11.00 | -- | 9.31 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -44.80m | 185.93m | 8.00 | -- | 9.25 | -- | -- | -0.1651 | -0.1651 | 0.00 | 0.0556 | 0.00 | -- | -- | -- | -122.57 | -57.97 | -179.56 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1145 | -- | -- | -- | 21.54 | -- | -- | -- |
| SenzaGen AB | -100.00bn | -100.00bn | 189.88m | 32.00 | -- | 2.89 | -- | -- | -- | -- | -- | 2.71 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 1.24 | -- | 0.0368 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Biovica International AB | 5.98m | -122.99m | 203.41m | 37.00 | -- | 1.62 | -- | 34.03 | -2.42 | -2.42 | 0.115 | 1.62 | 0.033 | -0.3053 | 8.43 | 170,800.00 | -67.80 | -42.10 | -74.69 | -46.33 | 110.09 | 277.88 | -2,057.41 | -2,149.68 | 7.10 | -- | 0.057 | -- | 65.43 | 4.44 | -84.14 | -- | -20.20 | -- |
| Kancera AB | 0.00 | -60.35m | 208.20m | 5.00 | -- | 2.22 | -- | -- | -0.7267 | -0.7267 | 0.00 | 0.7749 | 0.00 | -- | -- | 0.00 | -52.92 | -54.82 | -65.84 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Abliva AB | 137.00k | -97.60m | 222.38m | 6.00 | -- | 3.29 | -- | 1,623.20 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -24,869.34 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Opticept Technologies AB | 7.76m | -74.20m | 226.22m | 29.00 | -- | 0.6449 | -- | 29.16 | -2.26 | -2.26 | 0.2293 | 8.31 | 0.0193 | -0.061 | 4.94 | 267,517.30 | -18.54 | -41.76 | -20.15 | -46.21 | 125.86 | 62.65 | -959.65 | -882.41 | 0.6931 | -174.01 | 0.044 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
| Lumito AB (publ) | 17.00k | -25.67m | 233.69m | 14.00 | -- | 2.43 | -- | 13,746.31 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -47.60m | 233.79m | 8.00 | -- | 5.26 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
| Thor Medical ASA | 0.00 | -5.48m | 235.91m | 1.00 | -- | 0.876 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 238.12m | 4.00 | -- | 26.39 | -- | -- | -0.1765 | -0.1765 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Arctic Bioscience AS | 33.24m | -44.82m | 242.34m | 20.00 | -- | 0.9518 | -- | 7.29 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
| Intervacc AB | 8.93m | -102.77m | 243.87m | 15.00 | -- | 1.11 | -- | 27.32 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| Aqua Bio Technology ASA | 13.31m | -1.48m | 252.10m | 2.00 | -- | 11.90 | 295.74 | 18.95 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
Data as of Jun 14 2024. Currency figures normalised to Abliva AB's reporting currency: Swedish Krona SEK
1.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 May 2024 | 6.94m | 0.66% |
| Skandia Investment Management ABas of 30 Apr 2024 | 5.24m | 0.50% |
| SEB Investment Management ABas of 31 May 2024 | 3.45m | 0.33% |
| FCG Fonder ABas of 31 Dec 2023 | 2.68m | 0.25% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 637.46k | 0.06% |
| Skandia Fonder ABas of 30 Apr 2024 | 192.79k | 0.02% |
| Case Kapitalf�rvaltning ABas of 30 Nov 2022 | 14.57k | 0.00% |
More ▼
Data from 31 Dec 2022 - 30 Apr 2024Source: FactSet Research Systems Inc.
